Brain Circulation

REVIEW ARTICLE
Year
: 2021  |  Volume : 7  |  Issue : 4  |  Page : 241--246

Protection of multiple ischemic organs by controlled reperfusion


Jin Ma1, Ming Li2, Mengke Zhang1, Miuwen Jiang3, Yuan Gao3, Ruchi Mangal4, Yuchuan Ding5, Zhichen Yin6, Xunming Ji7,  
1 Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China
2 Department of Neurology, Xuanwu Hospital; ChinaAmerica Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
3 School of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing, China
4 Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
5 ChinaAmerica Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China; Department of Neurosurgery, Wayne State University School of Medicine, Detroit, MI, USA
6 ChinaAmerica Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing, China
7 Department of Neurology, Xuanwu Hospital; ChinaAmerica Institute of Neuroscience, Xuanwu Hospital, Capital Medical University; School of Instrumentation and Optoelectronic Engineering, Beihang University, Beijing, China

Correspondence Address:
Xunming Ji
Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, Beijing
China
Zhichen Yin
China-America Institute of Neuroscience, Xuanwu Hospital, Capital Medical University, Beijing
China

Abstract

Reperfusion injury (RI) is a harmful complication that takes place during recanalization treatment of ischemic organs. Currently, there are no efficacious treatments for protecting the organs against RI. Therefore, it is necessary to discover new strategies to prevent RI. As a novel intervention technique, controlled reperfusion has promising effects on protecting multiple organs from RI, and it is done by adjusting physical parameters of blood flow or chemical compositions of the reperfusion liquid. In this brief review, the status of various controlled reperfusion methods is presented, as well as their application in the protection of ischemic organs.



How to cite this article:
Ma J, Li M, Zhang M, Jiang M, Gao Y, Mangal R, Ding Y, Yin Z, Ji X. Protection of multiple ischemic organs by controlled reperfusion.Brain Circ 2021;7:241-246


How to cite this URL:
Ma J, Li M, Zhang M, Jiang M, Gao Y, Mangal R, Ding Y, Yin Z, Ji X. Protection of multiple ischemic organs by controlled reperfusion. Brain Circ [serial online] 2021 [cited 2022 Jan 18 ];7:241-246
Available from: http://www.braincirculation.org/text.asp?2021/7/4/241/333030


Full Text



 Introduction



Reperfusion injury (RI) is a complicated pathological process that is initiated by the recanalization of blocked blood vessels through the course of thrombolysis or thrombectomy, which leads to serious tissue damage and organ dysfunction.[1] The mechanism of RI is still not clear, but it is believed to be associated with increased reactive oxygen species, reductive antioxidant enzymes and growing inflammatory infiltration (e.g., the accumulation of neutrophils coming from the blood flow after a long time of ischemia).[2] RI has the potential to damage tissues and organs such as the heart, brain, lung, kidney, and small intestine. For instance, it usually occurs after coronary artery bypass grafting for coronary heart disease,[3] thrombolysis for stroke patients,[4] lung transplant,[5] aneurysm,[6] and surgeries of the small intestine[7] or extremities.[8] Existing therapies of RI are mainly pharmacologic administration such as free-radical scavengers,[9] calcium ion antagonists, apoptosis inhibitors, and nonpharmacologic protective strategies such as cardiopulmonary resuscitation.[10] The mechanism of the existing pharmacologic options is mainly reduction of reactive oxygen species and calcium, recovery of mitochondrial function. However, the side effect of drugs is inevitable, and the evaluation of these treatment methods is still under exploration whose potential clinical application should be evaluated in future clinical trials. Recently, with the developing research on the pathogenesis and therapeutic methods of RI, controlled reperfusion is proposed through the manipulation of physical parameters (infusion pressure, flow rate, temperature, etc.) and chemical compositions (ion content, drugs, acid-base balance, etc.). Among all the methods of controlled reperfusion, many studies suggested that ischemic postconditioning is a promising treatment strategy.[11]

 The Basic Concept of Controlled Reperfusion



Basic concept

The concept of controlled reperfusion was first proposed in vascular surgery in the 1960s.[12] Revascularization after aortic ischemia-induced RI. To lower the incidence of RI, controlled reperfusion was conducted by adjusting the physical parameters (infusion pressure, flow rate, temperature) as well as chemical compositions [ion content, drugs, acid-base balance, shown in [Table 1]].{Table 1}

Condition

The conditions of controlled reperfusion include physical parameters (reperfusion pressure, flow rate, temperature, etc.) as well as chemical compositions (ion content, drugs, acid-base balance, etc.). These interventions are promising methods of organ protection in clinical practice.[17]

Control of physical parameters

The adjustment of flow rate was mainly conducted by a slow and gradual supply of blood to the ischemic area to avoid damage of tissue resulting from abrupt reperfusion of blood. This adjustment could also improve the functional recovery of the nervous system. A study demonstrated that high flow rate reperfusion such as 18 ml/kg/min did not relieve cerebral RI.[13] Researchers found that the higher the flow rate was, the less cerebral blood flow would be. A high flow rate may cause brain edema without glycometabolic improvement (no significant difference in glucose uptake and utilization of brain). This could lead to major brain damage, and therefore, it is vital to control the time and velocity of the perfusate in the brain.

Avolio et al. pointed out that high-flow-rate reperfusion leads to damage of the cerebral small vessels and diseases, similar to stroke and cognitive impairment, etc.[14] If the blood pressure, as a result of reperfusion, is limited to 80-100 mmHg, then it will not only reduce the production of superoxide radical, but it will also avoid vascular endothelial injury. As characterized by Vinten-Johansen,[15] low-pressure reperfusion and ischemic postconditioning were related to controlled reperfusion, which induced less morphological damage and led to quicker functional recovery of the nervous system.

Controlled reperfusion has a buffer effect in the regulation of blood flow, and it is widely applied in many fields. For instance, lowering the initial reperfusion pressure improves functional and metabolic recovery in the rat model of ischemic myocardium; reducing reperfusion flow rate relieves edema and muscle injury in the pig model of ischemic skeletal muscle.[19] It is known that aortic surgery needs cardiac arrest, so measures are taken to protect the important organs from ischemia. Tissue metabolism is usually reduced through hypothermia, which relieves organic damage and results in the best restored internal environment.[12]

Control of chemical compositions

Besides physical parameters, the other essential component of controlled reperfusion is chemical composition. The change of reperfusion liquid composition such as blood-crystalloid solution, composed of glutamate, glucose, NaCl et al. rather than highly oxygenated pure blood, reduces the pathological damage caused by reperfusion. In addition, we may also adjust ion content or the pH of the extracellular fluid to maintain homeostasis.

First, we should ensure materials including glucose and amino acid supply during ischemia. Second, controlling the type and concentration of ions by reducing calcium or adding magnesium can avoid calcium overload. Furthermore, some chemicals such as calcium ion antagonists, vasodilatory agents, and antioxidants may alleviate pathological tissue damage.[15] A promising method to reduce myocardial RI was put forward by Guo.[18] He found that Paclitaxel (PTX) reduced RI by maintaining the normal structure of cellular microtubules and helping mitigate the tissue damage caused by hypoxia. Therefore, the addition of moderate PTX to reperfusion composition is beneficial to decrease the adverse reactions after reperfusion.

It is also desirable to limit leukocyte infiltration to adjust the pH of blood to reach the best metabolic status and to use mannitol to restrain cell edema, as studied by Gerald.[20] However, another research reduced calcium concentration by accelerating sodium-calcium exchange so that sodium overload increased blood pressure by water-sodium retention.[21] This was not the most favorable outcome, so the clinical benefit of changing chemical compositions of perfusate is still controversial.

 Research and Development of Controlled Reperfusion



Protection in ischemic cerebrovascular disease

As a vital field, cerebral controlled reperfusion is a new strategy of reperfusion, which emphasizes the perfusion time and perfusate volume during the treatment of RI. One-time infusion is changed into the controlled infusion. In addition, it is effective to reduce cerebral edema and cell apoptosis, as well as to reduce infarct size and improve neural functional recovery, and then improve the prognosis of ischemic stroke. Researchers found that moderate to severe leukoaraiosis significantly increases the risk of intracerebral haemorrhage.[22] Controlled reperfusion reduces hemorrhagic transformation together with white matter lesions in RI in acute ischemic stroke. Nevertheless, the key to relieve RI is putting these theories into practice.

A pilot animal study was conducted in 2018 by using a middle cerebral artery occlusion (MCAO) rat model to carry out controlled reperfusion by controlling the blood flow, which may reduce oxygen radicals as well as calcium overload. Xu divided 42 rats into Gradual Flow Restoration (GFR) group and Rapid Flow Restoration (RFR) group.[23] Each group contained 14 rats with respective 15, 30, 60 min of MCAO. The crux of GFR is increasing cerebral blood flow (CBF) to 40%–49% of the baseline value in the first 2 min, 60%–69% in the next 2 min, and gradually reaching the baseline value in 5 min. The main criteria of RFR are 80% CBF of baseline value in 30 s. The results show significant differences in the mean neural system severity score, median infarct ratio, mean apoptosis rate of nerve cells, and mean histopathological anomaly score, of which GFR is better than RFR. Specifically, the 30-min and 60-min groups show pronounced benefits. Thus, the authors conclude that GFR is more effective in relieving cerebral RI than RFR, of which 60 min of reperfusion is more protective.

Zhang divided adult gerbils into a complete reperfusion group and a gradual reperfusion group at random.[24] The latter was divided into ¼ and ½ CBF baseline reperfusion. After 10 min of reperfusion, they found that the complete reperfusion group had the worst damage to the hippocampus and the most severe neurocyte apoptosis, and the lowest neurological scores. The gradual reperfusion group showed significantly reduced neurological damage and decreased infarct areas. Ji et al. came up with an alternative method of neuroprotection for ischemic stroke, which perfused cold normal saline to the internal carotid discontinuously.[25] Ji's team used 85 MCAO Sprague-Dawley rats with the reperfusion rate of 15 ml/h for 30 min, followed by a 20-min rest interval, and then repeated the cycle three times. This study confirmed the safety and effectiveness of the controlled target hypothermia for neuroprotection.

In large animal studies, researchers mainly use the pig model [Figure 1] and carry out controlled reperfusion by blood flow volume and velocity. Allen et al. induced transient cerebral ischemia for 30 s and then conducted reperfusion for 5 min to the model.[26] The researchers found that the low reperfusion group of 450 cc/min had a better outcome than the high reperfusion group of 750 cc/min in reducing oxygen consumption, cerebral edema, and infarct areas. However, if the blood flow is lower than 450 cc/min, it may cause irreversible damage to the brain. Therefore, it is necessary to make sure that the minimum value is achieved to improve patients' prognosis.{Figure 1}

Clinical applications of controlled reperfusion have not been reported. From animal experiments, we can see GFR is more helpful to 30 or 60 min of MCAO rats than 15 min. Thus, the outcome of GFR may depend on the timing of revascularization of acute occlusion of intracranial arteries and a late onset may yield a better effect. One possible protection mechanism of GFR in reducing cerebral RI is the inhibition of calcium overload via decreasing the production of calcium to avoid neurocyte apoptosis.[17] The study may provide some insights into the treatment of ischemic stroke patients because it does not require extra medical apparatus or drugs. It is predicted that GFR combined with thrombectomy might be effective in preventing cerebral RI and improving prognosis, which needs to be confirmed by further research.[27] Above all, controlled reperfusion plays a vital role in neural protection by reducing cerebral RI, which is potentially applicable to clinical practice.

Protection in other organs

We also find several studies of controlled reperfusion in other organs besides the brain. Many researchers studied the protection of controlled reperfusion on using animal models through the control of blood flow volume within the organs such as the stomach,[28] hind limbs,[29] lung,[30] kidney[31] et al. [Table 2]. They find that GFR relieves RI and protects ischemic tissues from the sudden recovery of blood supply. Furthermore, controlled reperfusion is widely applied in the myocardium,[32] skeletal muscle,[29] cremaster[20] et al.{Table 2}

 Protection Mechanism of Controlled Reperfusion



Physical parameters

In the control of blood flow rate and pressure, Haldenwang et al. claim that high blood flow volume increases vascular resistance and hydrostatic pressure, which results in vascular endothelial dysfunction and even encephala edema.[33] On the contrary, controlled reperfusion avoids this problem, and it plays a vital role in maintaining intracellular pH values and ATP levels. Controlled reperfusion provides a gradual oxygen supply, in which the ischemic tissues have a certain process of adaption with less damage and quicker recovery. One possible mechanism is that GFR slows down the production of oxygen radicals to the benefit of an organic clearance mechanism. Zhang et al. hypothesized that controlled reperfusion was a type of ischemic postconditioning.[32] He explained that a gradual infusion, rather than opening up blood vessels immediately after ischemia, leads to ischemic damage at a lesser extent. The result indicated cardiac protection in reducing markers of myocardial damage such as creatine kinase, myocardial infarction areas, and apoptotic index. Moreover, he compared the three patterns of ischemic postconditioning, gradually increasing reperfusion, constant reperfusion, and gradually reduced reperfusion, which all provided better protection effects on the heart compared to the control group. Among them, gradually increased reperfusion has the best cardio-protection effect. Another mechanism for this beneficial effect is decreased inflammatory responses. For instance, Jancsó et al. detected less leukocyte radical production in the controlled reperfusion group [Figure 2].[12]{Figure 2}

In the control of temperature, research showed that hypothermia treatment on the brain tissue makes it more tolerant to ischemia by reducing energy consumption. Local hypothermia is induced by infusing cold perfusate via the internal carotid, which contributed to the relief of neurological impairment for stroke patients [Figure 3].[34]{Figure 3}

Chemical compositions

Oxygen radicals are important inducers of RI,[35] which are delivered with the oxygen into the ischemic area after the revascularization of the blood vessels. Therefore, to avoid the sudden outbreak of oxygen radicals, one study proposed perfusing hypoxic blood into the vessel during reperfusion. Researchers found that the vascular damage was less in this case than in the control group, which indicated that as a main source of RI, oxygen radicals could be reduced by controlled reperfusion. It can also relieve the destruction of the blood-brain barrier and inhibit the activation of immune inflammation.[36] Furthermore, controlled reperfusion is available by adjusting ion content to reduce calcium ion overload.[37],[38]

 Conclusion



Controlled reperfusion has been proven to be an effective approach to relieve RI. Research protects heart, brain, and other vital organs. It mainly consists of adjusting physical parameters of blood flow or chemical compositions of the reperfusion liquid. Therein, the control of blood flow volume is widely studied and put into practice. Patients with acute ischemic stroke are likely to benefit from controlled reperfusion. We propose that a new form of controlled reperfusion, especially gradual enlargement of the inner diameter of the blood vessel, may relieve RI of acute ischemic stroke.

Financial support and sponsorship

This work was supported by the National Natural Science Foundation of China (82027802, 61975017, 82102220), Beijing Municipal Natural Science Foundation (721220), and General Projects of Scientific and Technological Plan of Beijing Municipal Education Commission (KM202010025023).

Conflicts of interest

Prof. Xunming Ji is Editor-in-Chief, Prof. Yuchuan Ding is an Associate Editor of Brain Circulation. The article was subject to the journal's standard procedures, with peer review handled independently of them and their research groups.

References

1Menting TP, Ergun M, Bruintjes MH, Wever KE, Lomme RM, van Goor H, et al. Repeated remote ischemic preconditioning and isoflurane anesthesia in an experimental model of renal ischemia-reperfusion injury. BMC Anesthesiol 2017;17:14.
2Akbari G. Role of zinc supplementation on ischemia/reperfusion injury in various organs. Biol Trace Elem Res 2020;196:1-9.
3Korkmaz-Icöz S, Kocer C, Sayour AA, Kraft P, Benker MI, Abulizi S, et al. The sodium-glucose cotransporter-2 inhibitor canagliflozin alleviates endothelial dysfunction following in vitro vascular ischemia/reperfusion injury in rats. Int J Mol Sci 2021;22:7774.
4Poalelungi A, Tulbă D, Turiac E, Stoian D, Popescu BO. Remote ischemic conditioning may improve disability and cognition after acute ischemic stroke: A pilot randomized clinical trial. Front Neurol 2021;12:663400.
5Santos CH, Dourado DM, Silva BA, Pontes HB, Azevedo Neto E, Vendas GS, et al. Effect of ischemic postconditioning and atorvastatin in the prevention of remote lung reperfusion injury. Braz J Cardiovasc Surg 2018;33:115-21.
6Wang RK, Sun YY, Li GY, Yang HT, Liu XJ, Li KF, et al. MicroRNA-124-5p delays the progression of cerebral aneurysm by regulating FoxO1. Exp Ther Med 2021;22:1172.
7Zhu H, Li B, Bindi E, Lee C, Alganabi M, Lok MJ, et al. Remote ischemic conditioning avoids the development of intestinal damage after ischemia reperfusion by reducing intestinal inflammation and increasing intestinal regeneration. Pediatr Surg Int 2021;37:333-7.
8Normahani P, Khosravi S, Sounderajah V, Aslam M, Standfield NJ, Jaffer U. The effect of lower limb revascularization on flow, perfusion, and systemic endothelial function: A systematic review. Angiology 2021;72:210-20.
9Totzeck M, Hendgen-Cotta UB, Rassaf T. Nitrite-nitric oxide signaling and cardioprotection. Adv Exp Med Biol 2017;982:335-46.
10Mohseni M, Ziaeifard M, Abbasi Z. Protection against ischemia-reperfusion injury in prolonged resuscitation: A case report and review of literature. ARYA Atheroscler 2014;10:227-9.
11Jonker SJ, Menting TP, Warlé MC, Ritskes-Hoitinga M, Wever KE. Preclinical evidence for the efficacy of ischemic postconditioning against renal ischemia-reperfusion injury, a systematic review and meta-analysis. PLoS One 2016;11:e0150863.
12Jancsó G, Arató E, Hardi P, Nagy T, Pintér Ö, Fazekas G, et al. Controlled reperfusion decreased reperfusion induced oxidative stress and evoked inflammatory response in experimental aortic-clamping animal model. Clin Hemorheol Microcirc 2016;63:217-34.
13Tovedal T, Lubberink M, Morell A, Estrada S, Golla SS, Myrdal G, et al. Blood flow quantitation by positron emission tomography during selective antegrade cerebral perfusion. Soc Thorac Surg 2017;103:610-6.
14Avolio A, Kim MO, Adji A, Gangoda S, Avadhanam B, Tan I, et al. Cerebral haemodynamics: Effects of systemic arterial pulsatile function and hypertension. Curr Hypertens Rep 2018;20:20.
15Vinten-Johansen J. Controlled reperfusion is a rose by any other name. J Thorac Cardiovasc Surg 2015;150:1649-50.
16Buckberg GD. Controlled reperfusion after ischemia may be the unifying recovery denominator. J Thorac Cardiovasc Surg 2010;140:12-8,18.e1-2.
17Jiang W, Lv J, Zhang YY, Wang K. Controlled reperfusion against ischemia reperfusion injury. Transl Stroke Res 2018;15:231-43.
18Guo H, Zheng M, Jiao YB, Zheng H. Paclitaxel enhances the protective effect of myocardial ischemia preconditioning on ischemia/reperfusion injury in aged rat. Zhonghua Xin Xue Guan Bing Za Zhi 2018;46:719-24.
19Beyersdorf F. Protection of the ischemic skeletal muscle. Thorac Cardiovasc Surg 1991;39:19-28.
20Ozmen S, Ayhan S, Demir Y, Siemionow M, Atabay K. Impact of gradual blood flow increase on ischaemia-reperfusion injury in the rat cremaster microcirculation model. J Plast Reconstr Aesthet Surg 2008;61:939-48.
21Ichikawa H. Controlled reperfusion. Gen Thorac Cardiovasc Surg 2012;60:65-7.
22Rastogi A, Weissert R, Bhaskar SM. Emerging role of white matter lesions in cerebrovascular disease. Eur J Neurosci 2021;54:5531-59.
23Xu WW, Zhang YY, Su J, Liu AF, Wang K, Li C, et al. Ischemia reperfusion injury after gradual versus rapid flow restoration for middle cerebral artery occlusion rats. Sci Rep 2018;8:1638.
24Zhang D. Study of neural function rehabilitation by using low blood flow controlled reperfusion after gerbil global cerebral ischemia. Chin J Trauma 2005;21:27-30.
25Ji YB, Wu YM, Ji Z, Song W, Xu SY, Wang Y, et al. Interrupted intracarotid artery cold saline infusion as an alternative method for neuroprotection after ischemic stroke. Neurosurg Focus 2012;33:E10.
26Allen BS, Ko Y, Buckberg GD, Sakhai S, Tan Z. Studies of isolated global brain ischaemia: I. A new large animal model of global brain ischaemia and its baseline perfusion studies. Eur J Cardiothorac Surg 2012;41:1138-46.
27Linfante I, Cipolla MJ. Improving reperfusion therapies in the era of mechanical thrombectomy. Transl Stroke Res 2016;7:294-302.
28Perry MA, Wadhwa SS. Gradual reintroduction of oxygen reduces reperfusion injury in cat stomach. Am J Physiol 1988;254:G366-72.
29Unal S, Ozmen S, DemIr Y, Yavuzer R, LatIfoğlu O, Atabay K, et al. The effect of gradually increased blood flow on ischemia-reperfusion injury. Ann Plast Surg 2001;47:412-6.
30Fiser SM, Tribble CG, Kaza AK, Long SM, Kern JA, Cassada DC, et al. Adenosine A2A receptor activation decreases reperfusion injury associated with high-flow reperfusion. J Thorac Cardiovasc Surg 2002;124:973-8.
31Durrani NK, Yavuzer R, Mittal V, Bradford MM, Lobocki C, Silberberg B. The effect of gradually increased blood flow on ischemia-reperfusion injury in rat kidney. Am J Surg 2006;191:334-7.
32Zhang G, Sun Y, Wang Y, Bai J, Li T, Li X, et al. An improved postconditioning algorithm: Gradually increased reperfusion provides improved cardioprotection in rats. Mol Med Rep 2013;8:696-702.
33Haldenwang PL, Strauch JT, Amann I, Klein T, Sterner-Kock A, Christ H, et al. Impact of pump flow rate during selective cerebral perfusion on cerebral hemodynamics and metabolism. Ann Thorac Surg 2010;90:1975-84.
34Kurisu K, Abumiya T, Ito M, Gekka M, Osanai T, Shichinohe H, et al. Transarterial regional hypothermia provides robust neuroprotection in a rat model of permanent middle cerebral artery occlusion with transient collateral hypoperfusion. Brain Res 2016;1651:95-103.
35Mandalaneni K, Rayi A, Jillella DV. Stroke Reperfusion Injury. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021.
36Sharma D, Spring KJ, Bhaskar SM. Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis. Acta Neurol Scand 2021;144:486-99.
37Ravindran AV, Killingsworth MC, Bhaskar S. Cerebral collaterals in acute ischaemia: Implications for acute ischaemic stroke patients receiving reperfusion therapy. Eur J Neurosci 2021;53:1238-61.
38Bhaskar S, Bivard A, Stanwell P, Parsons M, Attia JR, Nilsson M, et al. Baseline collateral status and infarct topography in post-ischaemic perilesional hyperperfusion: An arterial spin labelling study. J Cereb Blood Flow Metab 2017;37:1148-62.